Glenmark Pharmaceuticals today said its board will meet later this week to consider buyback of its Singapore-listed foreign currency convertible bonds (FCCBs). “…a meeting of the Board of Directors of...
PE firm Advent International acquires 51% stake in ZCL Chemicals
Private equity firm Advent International has signed a definitive agreement to acquire a majority stake in ZCL Chemicals (ZCL), one the fastest-growing pharmaceutical firms in India. The business was formerly known as...
Jazz Pharma to buy GW Pharma for $7.2 billion, adding cannabis-based drug to portfolio
Jazz Pharmaceuticals Plc said on Wednesday it had agreed to buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal which will bolster its neuroscience business with the addition of cannabis-based epilepsy...
EQT raises bid for contract drugmaker Recipharm to 232 SEK/share
Buyout group EQT on Thursday raised its cash offer for contract pharmaceutical maker Recipharm, valuing the Swedish company at 24.9 billion Swedish crowns ($2.97 billion). EQT raised its bid to 232 crowns per share from...
Telehealth company Ro explores deal to go public: sources
Roman Health Ventures Inc, the company behind telehealth and online pharmacy business Ro, is in talks to go public through a merger with blank-check acquisition company which could value it at more than $4 billion...
Brazil antitrust regulator clears hurdle for Hypera-Takeda deal
Brazil’s antitrust regulator CADE said on Wednesday it had cleared the way for Hypera Pharma to buy a portfolio of productions from Japan’s Takeda Pharmaceutical Co. According to a source familiar with the matter, there...
AstraZeneca to buy Alexion for $39 billion in cash and shares
AstraZeneca Plc said it will buy Alexion Pharmaceuticals Inc. in a cash and share offer worth $39 billion, adding a specialist in the development of treatments for rare diseases and immunology. The offer values Alexion...
Everstone Capital to acquire controlling stake in Calibre
Private equity firm Everstone Capital has signed an agreement to acquire a controlling stake in Calibre, a specialty ingredients manufacturer of pharmaceutical, nutritional and personal care products, the investor said...
Merck sells stake in Moderna as vaccine gets FDA review
Merck & Co. said it sold its stake in Moderna Inc., the biotechnology company that’s in the midst of developing a Covid-19 vaccine. The shares of both companies rose. Merck sold its direct equity investment in...
Glenmark to sell select brands to Dr Reddy’s
Glenmark Pharmaceuticals Ltd has agreed to divest some of its anti-allergy medicine brands in Russia, Ukraine, Kazakhstan, and Uzbekistan to Dr Reddy’s Laboratories Ltd for an undisclosed amount, the two companies said...
Swiss drugmaker Vifor had bid interest but talks halted: sources
Swiss drugmaker Vifor Pharma had a recent takeover approach from at least one private equity firm, but talks were halted due to differences over price, two sources familiar with the situation said. The financial...
AstraZeneca sells commercial rights to two drugs in $400 million deal
AstraZeneca Plc said on Friday it would sell commercial rights for two of its drugs to a German pharmaceutical company for $400 million as the British drugmaker looks to focus on newer medicines in new therapy areas...
